Endovascular Management of Brain Arteriovenous Malformations
Seminars in Neurology · 01.06.2023 · 43 (03) · 323-336
DOI: 10.1055/a-2105-6614 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Seminars in Neurology, erschienen am 01.06.2023. Verfasst von Julien Ognard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Neuroradiology, Brest University Hospital, Brest, France. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Intracranial Arteriovenous Malformations, Endovascular Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben.
Abstract (Originalsprache)
Due to the risk of cerebral hemorrhage, and its related morbidity–mortality, brain arteriovenous malformations (bAVMs) are a rare and potentially life-threatening disease. Despite this, there is only one randomized controlled trial on bAVM management, A Randomized trial of Unruptured Brain Arteriovenous malformations (ARUBA). The results of the ARUBA trial favor a noninterventional approach in the case of an unruptured bAVM; however, implementation of these findings is challenging in daily practice. Instead, management of bAVM relies on multidisciplinary discussions that lead to patient-specific strategies based on patient preferences, local expertise, and experience in referral centers. Considering the diverse patterns of presentation and numerous treatment modalities, implementing standardized guidelines in this context proves challenging, notwithstanding the recommendations or expert opinions offered. Endovascular treatment (EVT) of bAVM can be curative, or can serve as an adjunct treatment prior to surgery or radiosurgery (“pre-EVT”). EVT practice is in constant evolution (i.e., venous approach, combination with surgery during the same anesthesia, etc.). Liquid embolic agents such as ethylene vinyl alcohol (EVOH) copolymer and cyanoacrylates (CYA), and their method of injection to increase bAVM occlusion have also benefited from technical evolutions such as the use of adjunctive flow arrest techniques (mini balloons, pressure cooker technique, and multiple catheters). Further research is necessary to evaluate the advantages and disadvantages of EVT for bAVM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Interventional Neuroradiology, Brest University Hospital, Brest, France.
- Inserm, UMR 1101 (Laboratoire de Traitement de l'Information Médicale-LaTIM), Université de Bretagne Occidentale, Brest, France.
- Department of Neurosurgery, Brest University Hospital, Brest, France.
- Department of Interventional Neuroradiology, NEURI Brain Vascular Center, Bicêtre Hospital, APHP, Paris Saclay University, Le Kremlin-Bicêtre, France.
- Division of Neuroradiology, Joint Department of Medical Imaging, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
- Inserm, UMR 1304 (GETBO), Western Brittany Thrombosis Study Group, Université de Bretagne Occidentale, Brest, France.
Zitieren
APA
Ognard, J., Magro, E., Caroff, J., Bodani, V., Mosimann, P. J., & Gentric, J. C. (2023). Endovascular Management of Brain Arteriovenous Malformations. Seminars in Neurology, 43(03), 323-336. https://doi.org/10.1055/a-2105-6614
Vancouver
Ognard J, Magro E, Caroff J, Bodani V, Mosimann PJ, Gentric JC. Endovascular Management of Brain Arteriovenous Malformations. Seminars in Neurology. 2023;43(03):323-336. doi:10.1055/a-2105-6614
BibTeX
@article{Ognard2023,
author = {Ognard, Julien and Magro, Elsa and Caroff, Jildaz and Bodani, Vivek and Mosimann, Pascal John and Gentric, Jean-Christophe},
title = {Endovascular Management of Brain Arteriovenous Malformations},
journal = {Seminars in Neurology},
year = {2023},
volume = {43},
number = {03},
pages = {323--336},
doi = {10.1055/a-2105-6614}
}
EUVIMED